Why Am I Still Hungry on Mounjaro?

What the SURMOUNT trial data actually shows about hunger and appetite

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity and found average body-weight reductions of around 20–21% at the highest dose over 72 weeks. Those are striking numbers, but the trial also recorded that GI symptoms and appetite fluctuations were most pronounced in the early months, suggesting that the appetite-suppressing effect is not uniform or instant across the treatment period.

Tirzepatide works by slowing gastric emptying and increasing satiety signals to the brain, which means food stays in your stomach longer and the sensation of fullness arrives sooner. What it does not do is eliminate every hunger signal. The brain's appetite system is layered: hormonal pathways are just one part of it. Emotional triggers, habitual eating patterns, stress hormones and poor sleep can each generate hunger independently of how much tirzepatide is in your system. So if you are asking why you feel hungry on Mounjaro, the honest answer is that the medicine was never designed to silence all of those at once.

There is also a dose dimension. If you are still on 2.5 mg, the dose your prescriber starts you on exists to let your digestive system adjust gradually, significant appetite reduction tends to arrive as the dose is titrated upward. Questions about whether you are on the right dose for your current stage are covered in more detail on our guide to hunger patterns on Mounjaro.

Head hunger vs physical hunger: why the distinction matters

A question our prescribers hear most weeks is some version of: "I'm not really hungry but I still want to eat, is that normal?" Yes, and there is a name for it: head hunger. Physical hunger, the kind driven by an empty stomach and falling blood glucose, is what tirzepatide is most effective at reducing. Head hunger is different: it is the pull you feel at 9 pm when the television is on, the reflex reach for something sweet after a stressful call, the habit of finishing what is on your plate regardless of fullness.

Many people find that when Mounjaro suppresses physical hunger strongly, head hunger becomes more noticeable precisely because it is no longer masked. This is not a side effect of the medicine; it is just what remains when the physiological noise is turned down. Recognising the difference is genuinely useful. If you eat in response to head hunger, you can still undermine the calorie deficit that tirzepatide is trying to create.

Practical responses include structured meal times rather than eating by appetite alone, adequate protein at each meal to sustain satiety between doses, and honest reflection on which triggers are habitual. The NHS advice on maintaining a healthy weight alongside lifestyle changes reinforces this point: medication works best when eating behaviour changes alongside it. For a closer look at what to put on your plate, our food guidance for Mounjaro covers protein targets, fibre and meal structure in practical terms.

Timing in your injection cycle and what to do about it

Mounjaro is injected once a week, which means its plasma concentration rises and then falls across seven days. Many people find hunger creeps back in the last day or two before their next injection. This is sometimes called the "end of week" dip, and it is a recognised pattern. It does not mean the medicine has stopped working; it reflects the natural pharmacokinetic curve of a weekly drug.

A few things can sharpen this effect. Eating very low-calorie amounts early in the week, then finding appetite returns sharply by day six, is a common trap. Eating too little overall can also trigger compensatory hunger that overrides the medicine's signal. Adequate hydration matters too, because thirst is frequently misread as hunger. If you are experiencing strong hunger specifically in this end-of-week window, it is worth discussing injection timing and meal distribution with your prescriber before assuming a dose increase is the answer.

There are also some less-obvious contributors. Disrupted sleep raises ghrelin, a hunger-stimulating hormone, and can blunt the appetite-suppressing signals that tirzepatide relies on. Some people notice that nights of poor sleep correlate with harder-to-manage hunger the next day. If unusual symptoms like night sweats are affecting your sleep, our page on Mounjaro and night sweats may be relevant. And if you are wondering whether what you are experiencing is typical or something to raise with a clinician, the fuller picture of why hunger feels different for different people on tirzepatide is worth reading.

For those thinking about the cost of private treatment, our Mounjaro pricing page sets out what a legitimate prescription service includes. If you have been taking tirzepatide for a while and the hunger issue has shifted, information on what happens when appetite suppression changes over time is on our page exploring persistent hunger at later stages of treatment.

If you are ready to discuss your situation with a clinician, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not an automated queue.